Many people suffer from chronic inflammation because their immune systems overreact to ‘self’ tissue. Scientists believe that a small molecule known as Interleukin 21 is a promising therapeutic target in such cases.
Many people suffer from chronic inflammation because their immune systems overreact to ‘self’ tissue. Scientists believe that a small molecule known as Interleukin 21 is a promising therapeutic target in such cases.